InsiderTrades

Form 4 for CBUS Cibus, Inc.

Accepted 2023-06-02 00:00:00 ET · period of report 2023-03-01 · accession 0001615594-23-000042 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-06-02 2023-05-31 CBUS Carr Michael A. Pres, CEO A - Grant $0.00 +15.5K 33.2K +88% $0
DM 2023-06-02 2023-03-01 CBUS Carr Michael A. Pres, CEO A - Grant — +690.0K 490.0K New —
DM 2023-06-02 2023-03-01 CBUS Carr Michael A. Pres, CEO D - Sale to Iss — -690.0K 0 -100% —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-05-31 A A 15,533 $0.00 33,174 D — — (F1) Shares were received for no consideration upon the satisfaction of performance criteria underlying the award of the performance share units. Shares reflect teh one-for-ten reverse stock split effected on April 24, 2023 and the one-for-five reverse stock split effected on May 31, 2023.
2 Derivative Stock Option (Right-to-Buy) 2023-03-01 A A 200,000 — 200,000 D $3.65 · — to 2031-07-27 200,000 Common Stock (F2) The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.
3 Derivative Stock Option (Right-to-Buy) 2023-03-01 D D 200,000 — 0 D $3.65 · — to 2031-07-27 200,000 Common Stock (F2) The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.
4 Derivative Stock Option (Right-to-Buy) 2023-03-01 A A 490,000 — 490,000 D $1.27 · — to 2033-03-24 490,000 Common Stock (F2) The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.
5 Derivative Stock Option (Right-to-Buy) 2023-03-01 D D 490,000 — 0 D $1.27 · — to 2033-03-24 490,000 Common Stock (F2) The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.